showed

Zacks Small Cap Research – CTSO: CytoSorbents Reports Preliminary 4th Quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT On January 3, 2025, CytoSorbents (NASDAQ:CTSO) reported strong preliminary 4th quarter and full year 2024 financial results which exceeded our expectations. 4th quarter product revenue (excluding grant income) is estimated to be in the range of $9.0-$9.2 million, which is approximately 22% to 25% … Read more

By no means a zealot, Fumio Kishida confirmed a stunning fearlessness – Go Well being Professional

by
By no means a zealot, Fumio Kishida confirmed a stunning fearlessness – Go Well being Professional

Unlock the Editor’s Digest totally free Roula Khalaf, Editor of the FT, selects her favorite tales on this weekly publication. In his early months as prime minister in 2021, the supposedly non-ideological Fumio Kishida did an enthusiastic flip as an ideologue.  Japan, in accordance with his imaginative and prescient, wanted to embrace the uplifting however … Read more

x